AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank60
3Y CAGR-94.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-94.5%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 101.55% |
| 2024 | -32.05% |
| 2023 | 327.81% |
| 2022 | 601396.95% |
| 2021 | -75.39% |
| 2020 | 0.00% |